Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens

Journal of Heart and Lung Transplantation

Volumn 25, Issue 3, 2006, Pages 276-282

  Law, Yuk M ^a,e   Yim, Robert ^a   Agatisa, Pat ^b   Boyle, Gerard J ^c   Miller, Susan A ^d   Lawrence, Kathy ^d   Webber, Steven A ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PREDNISONE; TSUKUBAENOLIDE;

ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT REJECTION; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MONITORING; PEDIATRIC SURGERY; PRIORITY JOURNAL; THORAX SURGERY; TRANSPLANTATION;

ADOLESCENT; ADULT; CALCINEURIN; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; CYCLOSPORINE; FEMALE; HEART TRANSPLANTATION; HUMANS; HYPERLIPIDEMIAS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; LIPIDS; MALE; PREDNISONE; TACROLIMUS;

EID: 33344456648     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.10.006     Document Type: Article

References (31)

1. M.J. Klag, D.E. Ford, L.A. Mead Serum cholesterol in young men and subsequent cardiovascular disease N Eng J Med 328 1993 313 318
2. K.M. Anderson, W.P. Castelli, D. Levy Cholesterol and mortality 30 years of follow-up from the Framingham Study JAMA 257 1987 2176 2180
3. M.R. Law, N.J. Wald, S.G. Thompson By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischemic heart disease? BMJ 308 1994 367 373
4. J.I. Cleeman, S.M. Grundy National Cholesterol Education Program recommendations for cholesterol testing in young adults a science-based approach Circulation 95 1997 1646 1650
5. K. Uzark, D. Crowley, L. Callow, E. Bove Hypercholesterolemia after cardiac transplantation in children Am J Cardiol 66 1990 1385 1387
6. J.M. Swenson, F.J. Fricker, J.M. Armitage Immunosuppression switch in pediatric heart transplant recipients cyclosporine to FK 506 J Am Coll Cardiol 25 1995 1183 1188
7. M.G. Penson, W.E. Winter, F.J. Fricker Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients J Heart Lung Transplant 18 1999 707 713
8. C. Chin, D. Rosenthal, D. Bernstein Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients Pediatr Transplant 4 2000 193 199
9. I.M. Seipelt, S.E. Crawford, S. Rodgers Hypercholesterolemia is common after pediatric heart transplantation Initial experience with pravastatin J Heart Lung Transplant 23 2004 317 322
10. M.M. Boucek, R.J. Novick, L.E. Bennett The registry of the International Society of Heart and Lung Transplantation second official pediatric report - 1998 J Heart Lung Transplant 17 1998 1141 1160
11. S.Z. Gao, J.S. Schroeder, S. Hunt, S.B. Stinson Retransplantation for severe accelerated coronary artery disease in heart transplant recipients Am J Cardiol 62 1988 876 881
12. D. Eich, J.A. Thompson, D.J. Ko Hypercholesterolemia in long term survivors of heart transplantation an early marker of accelerated coronary artery disease J Heart Lung Transplant 10 1991 45 49
13. L.D. Sharples, N. Caine, P. Mullins Risk factor analysis for the major hazards following heart transplantation - rejection, infection, and coronary occlusive disease Transplantation 52 1991 244 252
14. H. Valantine Role of lipids in allograft vascular disease a multicenter study of intimal thickening detected by intravascular ultrasound J Heart Lung Transplant 14 1995 S234 S237
15. H. Valantine Cardiac allograft vasculopathy after heart transplantation risk factors and management J Heart Lung Transplant 23 2004 S187 S193
16. P.R. Rickenbacher, M.S. Kemna, F.J. Pinto Coronary artery intimal thickening in the transplanted heart an in vivo intracoronary ultrasound study of immunologic and metabolic risk factors Transplantation 61 1996 46 53
17. A. Keogh, L. Simmons, P. Spratt Hyperlipidemia after heart transplantation J Heart Lung Transplant 7 1988 171 175
18. th Bethesda conference: cardiac transplantation. Task Force 5: complications JAMA 22 1993 41 54
19. V. Klausss, A. Konig, C. Spes Cyclosporine versus tacrolimus (FK 506) for prevention of cardiac allograft vasculopathy Am J Cardiol 85 2000 266 269
20. B. Reichart, B. Meiser, M. Vigano European multi-center tacrolimus (FK 506) heart pilot study one year results - European Tacrolimus Multicenter Study Group J Heart Lung Transplant 17 1998 775 781
21. D.O. Taylor, M.L. Barr, B. Radovancevic A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation decreased hyperlipidemia and hypertension with tacrolimus J Heart Lung Transplant 18 1999 336 345
22. B. Cantin, B. Kwok, N. Shiba, H.A. Valantine, S.A. Hunt, M.C. Chan Post-operative conversion from cyclosporine to tacrolimus in heart transplantation a single-center experience J Heart Lung Transplant 22 2003 723 730
23. T.B. Hickman, R.R. Briefel, M.D. Carroll Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years data from the Third National Health and Nutrition Examination Survey Prev Med 27 1998 879 890
24. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
25. D. Steinberg, A.M. Gotto Jr Preventing coronary artery disease by lowering cholesterol levels fifty years from bench to bedside JAMA 282 1999 2043 2050
26. S. Li, W. Chen, S. Srinivasan Childhood cardiovascular risk factors and carotid vascular changes in adulthood the Bogalusa Heart Study JAMA 290 2003 2271 2276
27. O.T. Raitakari, M. Juonala, M. Kähönen Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood the Cardiovascular Risk in Young Finns Study JAMA 290 2003 2277 2283
28. H.C. McGill, C.A. McMahan, G. Malcom, M.C. Oalmann, J.P. Strong PDAY Research Group Effects of serum lipoproteins and smoking on atherosclerosis in young men and women Arterioscler Thromb Vasc Biol 17 1997 95 107
29. P.H. Davis, J.D. Dawson, W.A. Riley, R.M. Lauer Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age the Muscatine study Circulation 104 2001 2815 2819
30. J.P. Strong, G.T. Malcom, C.A. McMahan Prevalence and extent of atherosclerosis in adolescents and young adults implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study JAMA 281 1999 727 735
31. American Academic of Pediatrics. Committee on Nutrition Cholesterol in childhood Pediatrics 101 1998 141 147